Original Article
Anthracycline-induced Tension in Permeabilized Cardiac Fibers: Evidence for the Activation of the Calcium Release Channel of Sarcoplasmic Reticulum

https://doi.org/10.1006/jmcc.1993.1032Get rights and content

Abstract

Anthracyclines, such as doxorubicin (DOX), are important cancer chemotherapeutic agents that are cardiotoxic. The mechanism for the cardiotoxicity is not well-defined. Recent studies have concluded that anthracyclines release calcium (Ca2+) from membrane fractions containing sarcoplasmic reticulum (SR). To determine whether anthracyclines release Ca2+in situ from cardiac SR, the effects of DOX on Ca2+-activated contractions were analyzed in membrane-permeabilized and membrane-intact fibers from rabbit heart. DOX (10-120 μM) induced tension development in calcium-preloaded permeabilized fibers. DOX-induced tension required submicromolar Ca2+, and was blocked by ruthenium red (20 μM) and Triton X-100 treatment, characteristics shared by caffeine-induced tension referable to SR Ca2+-release. DOX (50 μM) did not alter the maximum Ca2+-activated tension or shift the Ca2+ concentration-tension relationship of permeabilized fibers, indicating no effects of DOX on the myofilaments. DOX (44-350 μM) depressed post-rest isometric contractility of membrane-intact fibers but did not inhibit steady-state contractility (at 1 Hz; 2.5 Mm Ca2+), similar to effects of caffeine and submicromolar ryanodine. The specific effects of DOX on post-rest contractility of membrane-intact fibers are consistent with DOX-induced Ca2+ release from the SR of membrane-permeabilized fibers. Thus, DOX alters SR Ca2+ release in situ which may contribute to the inotropic and lusitropic dysfunction observed with anthracyclines.

References (0)

Cited by (37)

  • Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review

    2018, Critical Reviews in Oncology/Hematology
    Citation Excerpt :

    Intracellular Ca++ overload in the ventricle and mitochondria induced by DOX carries a lowering impact on an expenditure of energy, ending up as the depletion of high-energy phosphates (Ohhara et al., 1981). Besides this, DOX can cause changes in the transport and release of Ca++ in the myocardium (Boucek et al., 1993; Dodd et al., 1993; Ondrias et al., 1990). However, there has been conflicting evidence that cardiomyopathy due to DOX therapy initially relies more on Ca++ depletion rather than its accumulation (Zhou et al., 2001b).

  • Aliskiren attenuates myocardial apoptosis and oxidative stress in chronic murine model of cardiomyopathy

    2012, Biomedicine and Pharmacotherapy
    Citation Excerpt :

    Oxidative stress. Serum CK-MB and LDH are important myocardial enzymes in the evaluation of myocardial injury and congestive heart failure [47]. The serum levels of these enzymes were significantly elevated in the DXR treated group, whereas higher doses of ALK prevented this increase, indicating that direct inhibition of renin has cardioprotective efficacy against DXR toxicity.

  • Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy

    2006, Journal of the American College of Cardiology
    Citation Excerpt :

    Doxorubicin causes down-regulation of SERCA2 messenger RNA in animals with cardiac dysfunction (21). In addition, ANT has been noted to stimulate the release of Ca2+in cardiomyocytes (22). Carvedilol restores SERCA2 promoter activity in myocytes and it can block down-regulation of SERCA2 gene expression independent of its beta-blocking activity (23).

View all citing articles on Scopus
View full text